Unknown

Dataset Information

0

Optimizing ethambutol dosing among HIV/tuberculosis co-infected patients: a population pharmacokinetic modelling and simulation study.


ABSTRACT: BACKGROUND:Reduced ethambutol serum concentrations are commonly observed among TB patients co-infected with HIV and may lead to treatment failure. OBJECTIVES:To perform a population pharmacokinetic study of ethambutol in HIV/TB patients, and to evaluate an intensified ethambutol weight-based dosing strategy to support pharmacokinetic target attainment. METHODS:We conducted a prospective study of ethambutol pharmacokinetics among HIV/TB patients administered first-line TB treatment in Botswana, with study visits before and after initiation of ART. Clinical and disease status markers, including HIV-associated systemic immune activation and gut dysfunction biomarkers, were evaluated as covariates of ethambutol pharmacokinetic parameters in non-linear mixed effects analysis. Monte Carlo simulations were performed to compare pharmacokinetic target attainment under standard and intensified weight-based ethambutol dosing strategies. RESULTS:We studied 40 HIV/TB patients prior to initiation of ART, of whom 24 returned for a second visit a median of 33?days following ART initiation. Ethambutol serum concentrations were best explained by a two-compartment model with first-order elimination, with a significant improvement in oral bioavailability following ART initiation. In Monte Carlo simulations, a supplementary ethambutol dose of 400?mg daily led to >2-fold improvements in pharmacokinetic target attainment probabilities in lung tissue, both before and after ART initiation. CONCLUSIONS:Low serum ethambutol concentrations were commonly observed among HIV/TB patients in Botswana, and the oral bioavailability of ethambutol increased following ART initiation. Supplementary ethambutol dosing among HIV/TB patients may provide a strategy to optimize anti-TB treatment regimens in this high-risk population.

SUBMITTER: Mehta K 

PROVIDER: S-EPMC6753485 | biostudies-literature | 2019 Oct

REPOSITORIES: biostudies-literature

altmetric image

Publications

Optimizing ethambutol dosing among HIV/tuberculosis co-infected patients: a population pharmacokinetic modelling and simulation study.

Mehta Krina K   Ravimohan Shruthi S   Pasipanodya Jotam G JG   Srivastava Shashikant S   Modongo Chawangwa C   Zetola Nicola M NM   Weissman Drew D   Ivaturi Vijay V   Gumbo Tawanda T   Bisson Gregory P GP   Vinnard Christopher C  

The Journal of antimicrobial chemotherapy 20191001 10


<h4>Background</h4>Reduced ethambutol serum concentrations are commonly observed among TB patients co-infected with HIV and may lead to treatment failure.<h4>Objectives</h4>To perform a population pharmacokinetic study of ethambutol in HIV/TB patients, and to evaluate an intensified ethambutol weight-based dosing strategy to support pharmacokinetic target attainment.<h4>Methods</h4>We conducted a prospective study of ethambutol pharmacokinetics among HIV/TB patients administered first-line TB tr  ...[more]

Similar Datasets

| S-EPMC4834132 | biostudies-literature
| S-EPMC10864936 | biostudies-literature
| S-EPMC6477987 | biostudies-literature
| S-EPMC3284094 | biostudies-other
| S-EPMC4574838 | biostudies-literature
| S-EPMC10221211 | biostudies-literature
| S-EPMC5401970 | biostudies-literature
| S-EPMC3888951 | biostudies-literature
| S-EPMC4588417 | biostudies-literature
| S-EPMC3826734 | biostudies-literature